DDD Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History

DDD Partners’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-191,458	Closed	-$8.75M	–	57
2017 Q4	$8.75M	Buy	+191,458	New	+$9.55M	3.4%	11

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

DDD Partners's JUNO Position: Q1 2018 in Review

DDD Partners sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 191,458 shares — an estimated $8.75M sold.

DDD Partners first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $8.75M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

DDD Partners reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
DDD Partners sold 191,458 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $8.75M.
DDD Partners first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
DDD Partners's Juno Therapeutics, Inc. position peaked at $8.75M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on DDD Partners's 13F filing for Q1 2018, filed 4 May 2018.